Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
International Personal Finance
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Digital Lending And Interest Rate Caps Will Redefine Future Markets
Key Takeaways Regulatory caps, geopolitical risks, and FX volatility in key and emerging markets threaten revenue growth, earnings stability, and net margin improvement. Digital expansion and new products drive optimism, but operational, competitive, and regulatory challenges may limit scale, profitability, and future market share.
View narrative
UK£1.75
FV
18.9% overvalued
intrinsic discount
15.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
1 day ago
author updated this narrative
Invivyd
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Internal Sales And Antibody Pipeline Will Broaden Patient Reach
Key Takeaways Expansion of a skilled commercial team and new therapeutic programs positions Invivyd for broader market adoption, revenue growth, and reduced product concentration risk. Financial discipline and evolving regulatory support enhance sustainability, lower risk, and may fast-track product approvals and recurring revenue opportunities.
View narrative
US$2.93
FV
n/a
intrinsic discount
96.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
33
users have followed this narrative
Updated
narrative
STRATA Skin Sciences
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
CPT Reimbursement Expansion Will Augment Future Dermatology Opportunities
Key Takeaways Expanded insurance coverage and new reimbursement codes are expected to greatly increase STRATA's eligible patient pool and revenue growth opportunities. Strong clinical evidence and physician-focused initiatives are driving deeper device adoption, supporting sustained growth and competitive advantage.
View narrative
US$8.00
FV
n/a
intrinsic discount
4.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
Evolv Technologies Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets
Key Takeaways Expansion into large public sector contracts and direct subscription models is driving recurring revenue growth and improving customer relationships. Operational efficiencies and resolved legal issues are enhancing profitability, cash flow, and long-term earnings visibility.
View narrative
US$9.50
FV
n/a
intrinsic discount
19.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
Updated
narrative
Treace Medical Concepts
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Minimally Invasive Bunion Solutions Will Broaden Market Penetration
Key Takeaways Broadening of product portfolio and positive clinical adoption positions Treace for increased market penetration and long-term revenue growth. Improved cost discipline and expanding salesforce support enhanced margins and international market opportunities.
View narrative
US$8.35
FV
17.5% undervalued
intrinsic discount
9.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
DNA
Ginkgo Bioworks Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Life Sciences Automation Will Stagnate Amid Regulatory Challenges
Key Takeaways Overly optimistic revenue and margin expectations face obstacles from slow sector adoption, underused lab capacity, and challenges in monetizing new AI and data offerings. Regulatory, geopolitical, and competitive pressures may limit long-term growth, especially as customer acquisition and core-product commoditization risks increase.
View narrative
US$10.33
FV
27.5% overvalued
intrinsic discount
-9.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
49
users have followed this narrative
Updated
narrative
Navitas Semiconductor
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
GaN EV And Data Center Wins Will Unlock New Opportunities
Key Takeaways Projected growth in data centers and automotive sectors, supported by strategic partnerships and a robust backlog of design wins, boosts future revenue outlook. Cost-reduction initiatives aim to improve net margins and support positive EBITDA, enhancing financial positioning for 2026.
View narrative
US$6.74
FV
2.7% overvalued
intrinsic discount
31.07%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
69
users have followed this narrative
2 days ago
author updated this narrative
Dye & Durham
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Upgraded Workflow Software And Debt Reduction Will Secure Future Success
Key Takeaways Emphasis on organic growth and enhanced software could boost revenue via higher adoption and customer satisfaction. Debt reduction and strategic divestments may strengthen cash flow and financial health.
View narrative
CA$15.75
FV
32.9% undervalued
intrinsic discount
2.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
2 days ago
author updated this narrative
Wolfspeed
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Greenfield Facilities And CHIPS Act Support Will Drive Operational Success
Key Takeaways Closing inefficient facilities will lower the breakeven point, enhancing net margins through reduced operating costs. Advancements in 200-millimeter technology position Wolfspeed to capture market share in the growing EV and renewable energy sectors, driving revenue growth.
View narrative
US$4.13
FV
67.3% undervalued
intrinsic discount
12.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
68
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies